The Experimental Therapeutics program members work to find new drug therapies for cancer and to design more effective drugs that specifically target cancer and are less toxic.
The program unites investigators from UMMC and the University of Mississippi and physicians at UMMC in efforts find new products with anti-cancer properties and test it on specific cancers.
The program unites basic researchers, translational researchers and physicians to more quickly identify and develop new therapies, to make those therapies highly effective and to minimize side effects.
Dr. Shou-Ching Tang, associate director for clinical and translational research, heads the program.
Members of this program search for: